Omnicell Net Income 2012-2025 | OMCL

Omnicell net income from 2012 to 2025. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Omnicell Annual Net Income
(Millions of US $)
2025 $2
2024 $13
2023 $-20
2022 $6
2021 $78
2020 $32
2019 $61
2018 $38
2017 $31
2016 $10
2015 $31
2014 $31
2013 $24
2012 $16
2011 $10
Omnicell Quarterly Net Income
(Millions of US $)
2025-12-31 $-2
2025-09-30 $5
2025-06-30 $6
2025-03-31 $-7
2024-12-31 $16
2024-09-30 $9
2024-06-30 $4
2024-03-31 $-16
2023-12-31 $-14
2023-09-30 $6
2023-06-30 $3
2023-03-31 $-15
2022-12-31 $-28
2022-09-30 $17
2022-06-30 $9
2022-03-31 $8
2021-12-31 $14
2021-09-30 $29
2021-06-30 $20
2021-03-31 $14
2020-12-31 $16
2020-09-30 $9
2020-06-30 $-4
2020-03-31 $11
2019-12-31 $22
2019-09-30 $20
2019-06-30 $16
2019-03-31 $3
2018-12-31 $15
2018-09-30 $14
2018-06-30 $7
2018-03-31 $3
2017-12-31 $31
2017-09-30 $8
2017-06-30 $2
2017-03-31 $-10
2016-12-31 $9
2016-09-30 $2
2016-06-30 $-1
2016-03-31 $0
2015-12-31 $8
2015-09-30 $8
2015-06-30 $9
2015-03-31 $6
2014-12-31 $9
2014-09-30 $7
2014-06-30 $8
2014-03-31 $6
2013-12-31 $7
2013-09-30 $8
2013-06-30 $6
2013-03-31 $3
2012-12-31 $6
2012-09-30 $7
2012-06-30 $1
2012-03-31 $2
2011-12-31 $4
2011-09-30 $3
2011-06-30 $3
2011-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.664B $1.185B
Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $30.189B 34.91
Tempus AI (TEM) United States $9.769B 0.00
Hims & Hers Health (HIMS) United States $5.240B 42.63
Doximity (DOCS) United States $5.221B 22.18
IRhythm Holdings (IRTC) United States $4.719B 0.00
Privia Health (PRVA) United States $2.705B 169.15
Hinge Health (HNGE) United States $2.454B 0.00
Heartflow (HTFL) United States $2.362B 0.00
10x Genomics (TXG) United States $2.355B 0.00
Inspire Medical Systems (INSP) United States $1.909B 31.59
Azenta (AZTA) United States $1.321B 53.19
Enovis (ENOV) United States $1.292B 6.78
Clover Health Investments (CLOV) United States $1.101B 0.00
Schrodinger (SDGR) United States $0.994B 0.00
Butterfly Network (BFLY) United States $0.854B 0.00
Phreesia (PHR) United States $0.736B 0.00
Fulgent Genetics (FLGT) United States $0.725B 0.00
Talkspace (TALK) United States $0.643B 129.33
Standard BioTools (LAB) United States $0.485B 0.00
Claritev (CTEV) United States $0.428B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.324B 0.00
Evolent Health (EVH) United States $0.318B 0.00
Carlsmed (CARL) United States $0.310B 0.00
TruBridge (TBRG) United States $0.304B 13.97
Senseonics Holdings (SENS) United States $0.304B 0.00
Zepp Health (ZEPP) Netherlands $0.256B 0.00
CapsoVision (CV) United States $0.232B 0.00
KORU Medical Systems (KRMD) United States $0.228B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.210B 0.00
MDxHealth SA (MDXH) Belgium $0.167B 0.00
Nyxoah SA (NYXH) Belgium $0.158B 0.00
Health Catalyst (HCAT) United States $0.152B 0.00
CareCloud (CCLD) United States $0.104B 5.70
Outset Medical (OM) United States $0.082B 0.00
American Well (AMWL) United States $0.073B 0.00
NetraMark Holdings (AINMF) Canada $0.065B 0.00
111 (YI) China $0.064B 0.00
Pulmonx (LUNG) United States $0.062B 0.00
HeartBeam (BEAT) United States $0.049B 0.00
EUDA Health Holdings (EUDA) Singapore $0.042B 0.00
Precipio (PRPO) United States $0.035B 0.00
Evaxion - (EVAX) Denmark $0.028B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
Lunai Bioworks (LNAI) United States $0.016B 0.00
P3 Health Partners (PIII) United States $0.015B 0.00
Movano (MOVE) United States $0.012B 0.00
HeartSciences (HSCS) United States $0.010B 0.00
ITonic Holdings (ITOC) China $0.007B 0.00
Bullfrog AI Holdings (BFRG) United States $0.007B 0.00
Strata Skin Sciences (SSKN) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.006B 0.00
PROFUSA (PFSA) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Healthcare Triangle (HCTI) United States $0.001B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00